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ABSTRACT MicroRNAs (miRNAs) are short, noncoding RNAs involved in the regu-
lation of several processes associated with inﬂammatory diseases and infection.
Bacterial infection modulates miRNA expression to subvert any innate immune
response. In this study we analyzed, using microarray analysis, the bacterial mod-
ulation of miRNAs in bone marrow-derived macrophages (BMMs) in which activ-
ity was induced by infection with Porphyromonas gingivalis. The expression of
several miRNAs was modulated 3 h postinfection (at a multiplicity of infection of
25). A bioinformatic analysis was performed to further identify pathways related
to the innate immune host response under the inﬂuence of selected miRNAs. To
assess the effects of the miRNAs identiﬁed on cytokine secretion (tumor necrosis
factor alpha [TNF-] and interleukin-10 [IL-10]), BMMs were transfected with se-
lected miRNA mimics and inhibitors. Transfection with mmu-miR-155 and mmu-
miR-2137 did not modify TNF- secretion, while their inhibitors increased it. In-
hibitors of mmu-miR-2137 and mmu-miR-7674 increased the secretion of the
anti-inﬂammatory factor IL-10. In P. gingivalis-infected BMMs, mmu-miR-155-5p
signiﬁcantly decreased TNF- secretion while inhibitor of mmu-miR-2137 in-
creased IL-10 secretion. In vivo, in a mouse model of P. gingivalis-induced calvar-
ial bone resorption, injection of mmu-miR-155-5p or anti-mmu-miR-2137 reduced
the size of the lesion signiﬁcantly. Furthermore, anti-mmu-miR-2137 signiﬁcantly
reduced inﬂammatory cell inﬁltration, osteoclast activity, and bone loss. Bioinfor-
matic analysis demonstrated that pathways related to cytokine- and chemokine-
related pathways but also osteoclast differentiation may be involved in the ef-
fects observed. This study contributes further to our understanding of P.
gingivalis-induced modulation of miRNAs and their physiological effects. It high-
lights the potential therapeutic merits of targeting mmu-miR-155-5p and mmu-
miR-2137 to control inﬂammation induced by P. gingivalis infection.
KEYWORDS Porphyromonas gingivalis, inﬂammation, innate immunity, macrophages,
miRNA
Periodontitis (PD) is a common chronic inﬂammatory disease that can induce thedestruction of tooth-supporting tissues (1, 2) and has been linked to several
systemic diseases, such as cardiovascular disease (3, 4). The pathogenesis of PD is
associated with a dysbiosis of the periodontal microbiota. This dysbiosis is character-
ized by a shift from a symbiotic microbial community to a pathogenic one that is
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composed mainly of anaerobic bacteria, resulting in alteration of the host-microbe
cross talk (4). Porphyromonas gingivalis is a Gram-negative anaerobic bacterium that is
considered a keystone pathogen (4). It produces several virulence factors such as
lipopolysaccharide (LPS) and ﬁmbriae in order to activate macrophages (5, 6) and
invade different cell types, such as endothelial (7) and epithelial cells (8, 9). Several
mechanisms, such as modulation of gene and protein expression, are used by P.
gingivalis to compromise immune function at the periodontal level (1, 3). For instance,
in epithelial cells, P. gingivalis, through its LPS, increases the secretion not only of
several proinﬂammatory cytokines, including tumor necrosis factor alpha (TNF-) and
interleukin-6 (IL-6), but also of anti-inﬂammatory cytokines such as IL-10, demonstrating
the complexity of the cell’s response to infection (10). These inﬂammatory processes
and immune responses activated after bacterial infection are also responsible for tissue
destruction.
Macrophages are pivotal cells in the host response because of their direct contact
with infectious agents or their by-products (5, 11). These cells are often found in
chronic-PD-diseased tissues (12) and represent an important fraction of the total
inﬂammatory cell population (13). P. gingivalis is known to be able to invade macro-
phages (14) and to induce an important modulation of gene expression, resulting in the
synthesis of several mRNAs related to signaling, apoptosis, cytokine receptors, and
chemokine pathways (3, 6). Because posttranscriptional regulation may occur speciﬁ-
cally through microRNAs (miRNAs), it is important to note that it is not known if these
mRNA modulations have biological consequences.
Recognized as critical mediators in gene expression, miRNAs are short, noncoding
RNAs involved in many physiological and pathological processes (1, 3, 15). In recent
years, several roles for miRNAs in numerous inﬂammatory diseases, such as cardiovas-
cular diseases, diabetes, obesity, arthritis, and PD, have been described (16). Partially
complementary to the sequence of mRNAs in the 3= untranslated region, miRNAs can
downregulate gene expression at the posttranscriptional level (17). However, the
identiﬁcation of miRNA expression and the roles of miRNAs in inﬂammatory and
infectious diseases are not fully understood. Analysis of the modulation of miRNA
expression in infectious and inﬂammatory diseases may lead to the identiﬁcation of
new potential biomarkers and therapeutics (16).
In the context of PD, the impact of miRNA expression induced by infection with
common periodontal pathogens such as P. gingivalis has been evaluated mostly in
gingival tissue samples. Several miRNAs that can be differentially expressed in healthy
and diseased tissues have been described (18). However, a precise correlation between
speciﬁc pathogens and the different cell types involved in periodontal destruction has
not been made.
The aims of this study were to identify miRNAs differentially expressed by macro-
phages in response to P. gingivalis infection and to assess their impact at the cytokine
level. Furthermore, we wanted to evaluate, in vitro and in vivo, the ability of miRNAs
with anti-inﬂammatory properties to reduce inﬂammatory effects associated with P.
gingivalis infection. A bioinformatic pathway analysis revealed signal transduction
targets associated with the most promising miRNAs.
RESULTS
miRNAs differentially expressed in control and infected cells. To evaluate the
effects of P. gingivalis infection on the miRNA expression proﬁle in BMMs, the expres-
sion proﬁle of 1,908 mouse miRNAs was subjected to microarray analysis. A total of 203
miRNAs showed differential expression with a false discovery rate-corrected P (q) value
of 0.25, and clustering trends appeared between the groups (see Fig. S1 in the
supplemental material). The analysis was restricted to the most differentially expressed
miRNAs identiﬁed with higher-stringency parameters (a threshold of a 2- or 2-fold
change and P and q values of 0.001). As a result, eight miRNAs were identiﬁed as
differentially expressed between BMMs and the P. gingivalis-infected BMMs. Five miR-
NAs were upregulated (mmu-miR-7674-5p, mmu-miR-6975-5p, mmu-miR-155-5p,
Huck et al. Infection and Immunity
March 2017 Volume 85 Issue 3 e00771-16 iai.asm.org 2
 o
n
 July 5, 2018 by NEW
 YO
RK M
EDICAL CO
LLEG
E
http://iai.asm
.org/
D
ow
nloaded from
 
mmu-miR-347-3b, mmu-miR-347-3e), and three were downregulated (mmu-miR-2137,
mmu-miR-8109, mmu-miR-211-3p) (Table 1). The results obtained with the microarray
analysis were validated by reverse transcription (RT)-quantitative PCR (qPCR) for all of
the miRNAs identiﬁed except mmu-miR-6975-5p and mmu-miR-8109 because of primer
GC content and technical issues (Table 1).
Predicting the targets of differentially expressed miRNAs. To assist in the
selection of miRNAs with potential impact on the host response and identify the
biological pathways that may be affected by these miRNAs, a bioinformatic analysis was
performed. Therefore, after having analyzed the putative mRNA targets of the miRNAs
differentially expressed in naive BMMs and P. gingivalis-infected BMMs, 3,796 potential
target genes were predicted. The number of predicted target genes varied from 44
(mmu-miR-8109) to 1,262 (mmu-miR-6975-5p). Interactions of target genes were ex-
tracted from the STRING database, and the resulting protein-protein interaction (PPI)
network was visualized with Cytoscape. To facilitate analysis, only proteins with at least
two interactions with identiﬁed targets were considered. The network contains 6,746
nodes and 51,470 edges, where nodes represent target genes and edges represent
interactions between target genes. Topological modules (densely connected regions)
were identiﬁed by the Markov clustering (MCL) algorithm. A total of 639 modules were
identiﬁed, 211 of which contained 5 nodes, and the largest module contained 613
nodes. Pathway analysis led to the identiﬁcation of miRNA target genes in several
pathways related to the inﬂammatory response, including chemokine signaling path-
ways and cytokine-cytokine receptor interactions (Table 2). Interestingly, even if several
pathways related to a cell’s life were identiﬁed, such as the cell cycle, ribosome,
spliceosome, from the 10th largest identiﬁed topological modules, three of them were
linked to pathways related to the inﬂammatory response highlighting the potential
involvement of identiﬁed miRNAs in the modulation of the inﬂammatory response in P.
gingivalis-infected BMMs.
Impact of identiﬁed miRNAs on TNF- and IL-10 secretion in BMMs. To evaluate
the effects of the miRNAs identiﬁed on the inﬂammatory response, BMMs were
transfected with mimics and inhibitors of the most differentially expressed miRNAs
(mmu-miR-155-5p, mmu-miR-2137, mmu-miR-7674, mmu-miR-8109). This experiment
was aimed at evaluating the speciﬁc effect of each miRNA to assess its role in the
inﬂammatory response to P. gingivalis infection and especially in proinﬂammatory
TNF- and anti-inﬂammatory IL-10 secretion.
Transfection of BMMs with miR-155 and miR-2137 did not signiﬁcantly modify TNF-
secretion, while their respective inhibitors signiﬁcantly increased its secretion level.
Regarding miR-7674 and miR-8109, transfection induced an increase in TNF- to a
lesser extent than transfection with the respective inhibitors (Fig. 1A).
Regarding IL-10 secretion, only a few of the miRNAs tested modiﬁed its secretion
proﬁle signiﬁcantly. Mimics of mmu-miR-7674 and inhibitors of mmu-miR-2137 and
TABLE 1 Differential expression of miRNAs between BMMs infected with P. gingivalis and
control
miRNA differentially expressed upon
P. gingivalis infectiona Fold change
Upregulated
mmu-miR-7674-5pb 27.3
mmu-miR-6975-5p 4.4
mmu-miR-3473bb 2.7
mmu-miR-3473eb 2.7
mmu-miR-155-5pb 5.4
Downregulated
mmu-miR-8109 3.3
mmu-miR-2137b 3.2
mmu-miR-211-3pb 2.4
aThese genes were identiﬁed by a threshold of a 2- or 2-fold change and P and q values of 0.001.
bmiRNA expression validated by RT-qPCR.
P. gingivalis Modulation of miRNA Expression Infection and Immunity
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mmu-miR-8109 induced a signiﬁcant increase in IL-10 release in comparison with that
in the control (P  0.05) (Fig. 1B). Therefore, it appears that the miRNAs identiﬁed are
able to modulate the secretion rate of these two cytokines.
BMM transfection with selected miRNAs modulates cytokine secretion induced
by P. gingivalis infection. To evaluate if concomitant exposure to selected miRNAs is
able to modulate a cell’s response to P. gingivalis infection, transfected BMMs were
infected and TNF-/IL-10 secretion was evaluated. Interestingly, transfection with
TABLE 2 Predicted pathways of the identiﬁed targets gene of selected miRNAsa
Topological module and predicted pathways Benjamini-corrected P value
1 Olfactory transduction 0.0E0
2
Neuroactive ligand-receptor interaction 1.2E-107
Taste transduction 4.9E-36
Calcium signaling pathway 1.5E-19
Chemokine signaling pathway 2.7E-17
Cytokine-cytokine receptor interaction 4.3E-8
Complement and coagulation cascades 5.7E-6
CyclicAMP signaling pathway 6.6E-6
3
Ribosome 1.2E-141
Protein export 1.3E-19
4
Cell cycle 3.0E-86
Progesterone-mediated oocyte maturation 1.7E-25
Oocyte meiosis 1.7E-24
HTLV-I infection 1.8E-13
p53 signaling pathway 6.8E-12
Viral carcinogenesis 20.7E-11
Ubiquitin-mediated proteolysis 8.7E-11
Small-cell lung cancer 2.3E-9
Hepatitis B 1.2E-8
FoxO signaling pathway 3.5E-8
Pathways in cancer 2.3E-7
5
PPAR signaling pathway 2.4E-21
Thyroid hormone signaling pathway 1.2E-19
Adipocytokine signaling pathway 3.6E-7
Bile secretion 4.3E-5
aThe predicted pathways of the ﬁve largest topological modules are presented. Only pathways with a
Benjamini-corrected P value of 0.00001 were considered. Boldface type indicates pathways related to
immune and inﬂammatory response.
FIG 1 (A) TNF- secretion in transfected BMMs with selected miRNAs and their inhibitors (*, P  0.05). (B) IL-10 secretion in transfected BMMs with selected
miRNAs and their inhibitors (*, P  0.05). Pg, P. gingivalis.
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miR-155 signiﬁcantly decreased TNF- secretion by 30% (Fig. 2A). However, this effect
was not observed with other mimics or inhibitors. Regarding IL-10 secretion, the
transfection of anti-miR-2137 signiﬁcantly increased IL-10 secretion (Fig. 2B) while
miR-155 and anti-miR-7674 decreased it signiﬁcantly (P  0.05).
Taken together, these data show that transfection with miRNAs, especially miR-155
or anti-miR-2137, modulates the host response to P. gingivalis infection.
Effects of miR-155 and anti-miR-2137 in vivo. In this context, an in vivo proof-
of-concept experiment was conducted to assess the potential effects of miR-155 and
anti-miR-2137 in a mouse model of calvarial bone resorption induced by P. gingivalis
infection. To determine their potential roles in the inﬂammatory response and bone
resorption, selected miRNAs were injected concomitantly with P. gingivalis into mouse
calvaria. After 7 days, the area of the induced lesion in each mouse was measured (Fig.
3A), and the mean area was 11.08  1.47 mm2. The injection of miR-155 or anti-miR-
2137 alone concomitantly with P. gingivalis signiﬁcantly decreased the size of the lesion
(7.55  1.6 and 6.42  1.4 mm2, respectively), demonstrating a modulation of the
inﬂammatory process in vivo.
Histological examinations showed some degree of inﬂammatory cell inﬁltration (ICI;
leukocytes, lymphocytes, and macrophages) in all of the groups (Fig. 4) in comparison
with untreated mice (see Fig. S2). However, animals infected with P. gingivalis and
treated with anti-miR-2137 showed a reduced amount of inﬂammation (Fig. 4G and H),
in comparison with the P. gingivalis-infected group (Fig. 4A and B), supported by our
quantitative analysis (Fig. 3B). P. gingivalis infection induced bone resorption (Fig. 4C)
correlated with increased osteoclast activity, as evidenced by resorption lacunae. When
anti-miR-2137 was injected concomitantly with the infection, a signiﬁcant reduction of
calvarial bone loss and osteoclast activity (Fig. 3C and D) was observed, while mice
injected with miR-155 did not show signiﬁcantly reduced ICI, bone loss, or osteoclast
activity. However, while no signiﬁcant reduction of ICI was observed in the combination
group, a trend toward reduction of bone loss and osteoclast activity was observed (Fig.
3C and D).
Identiﬁcation of potential pathways targeted by mmu-miR-155 and mmu-miR-
2137. As some biological effects have been observed in vitro and in vivo, a new set of
bioinformatic analyses regarding mmu-miR-155 or mmu-miR-2137 were performed to
determine which molecular pathway can be linked to the results observed.
Regarding mmu-miR-155, 130 topological modules were identiﬁed by the MCL
algorithm, 52 of which contained more than ﬁve nodes. When the largest topological
modules (see Fig. S3) were considered, several pathways related to the inﬂammatory
response but also pathogen recognition were identiﬁed as potential targets, including
cytokine- and chemokine-related pathways and the Toll-like receptor (TLR) signaling
FIG 2 (A) Dosages of TNF- in supernatants of transfected BMMs infected with P. gingivalis (Pg) at 24 h. *, P  0.05 versus P.
gingivalis plus scramble. (B) Dosages of IL-10 in supernatants of transfected BMMs infected with P. gingivalis at 24 h. *, P 0.05
versus P. gingivalis plus scramble.
P. gingivalis Modulation of miRNA Expression Infection and Immunity
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pathway but also osteoclast differentiation. Furthermore, gene ontology analysis con-
ﬁrmed the potential involvement of this miRNA in the genes associated with the
inﬂammatory response (Benjamini-corrected P value, 1.3E-24). Interestingly, one other
topological module (see Fig. S4) was related to the Jak-STAT pathway, a well-described
pathway related to apoptosis but also to proinﬂammatory cytokine production, notably
through targeting of the TNF and NF-B signaling pathways. Furthermore, associations
with pathways related to epithelial cell invasion and osteoclast differentiation have also
been underlined for this module, especially through direct targeting of the phospha-
tidylinositol 3-kinase–AKT pathway.
Regarding mmu-miR-2137, 10 topological modules were identiﬁed, 4 of which
contained more than ﬁve nodes. The largest module was associated with the cell cycle
(Benjamini-corrected P value, 2.1E-12). However, no pathway related to inﬂammation
has been identiﬁed yet.
DISCUSSION
This study aimed to evaluate the effects of P. gingivalis infection on miRNA expres-
sion in BMMs and to evaluate their role in the inﬂammatory host response in vitro and
in vivo. This wide-scale analysis led to the identiﬁcation of several miRNAs that are
differentially expressed in infected cells. To determine the effects associated with this
modulation and potential implications for the innate immune response, a focus was
placed on miRNAs that have a high level of signiﬁcance. Therefore, analyses at the gene
level, through bioinformatic prediction, and at the protein level of cytokine secretion
were conducted that suggest roles for mmu-miR-155-5p, mmu-miR-2137, mmu-miR-
7674, and mmu-miR-8109 in P. gingivalis-induced host response modulation. Interest-
ingly, the present study also shows the potential of using speciﬁc miRNAs as a
FIG 3 (A) Sizes of calvarial lesions 7 days after P. gingivalis (Pg; 5  108 CFU) infection and the injection of miR-155 and anti-miR-2137. *, P  0.05, n  4. (B)
Quantitative analysis of the index of ICI in each of the following groups: P. gingivalis-only infected, combination group (P. gingivalis and anti-miR-2137 plus
miR-155), P. gingivalis and anti-miR-2137, and P. gingivalis and miR-155. *, P 0.05. (C) Quantitative analysis of calvarial bone resorption in each of the following
groups: P. gingivalis-only infected, combination group (P. gingivalis and anti-miR-2137 plus miR-155), P. gingivalis and anti-miR-2137, and P. gingivalis and
miR-155. *, P  0.05. (D) Quantitative analysis of osteoclast activity in each of the following groups: P. gingivalis-only infected, combination group (P. gingivalis
and anti-miR-2137 plus miR-155), P. gingivalis and anti-miR-2137, and P. gingivalis and miR-155. *, P  0.05.
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therapeutic approach to control the P. gingivalis-induced inﬂammatory response in a
mouse model of inﬂammation and bone resorption.
The capacity for modulation of the host response to P. gingivalis infection is part of
the bacterial survival strategy. Several mechanisms have been developed by such
bacteria in order to invade and proliferate within the host cell, whether at the gene (6)
or the protein (19, 20) level. Regulation of protein expression is critically important in
homeostasis and pathology. Because miRNAs have been shown to control 30% of all
protein-coding genes and also to participate in the regulation of almost every cellular
process (17, 21), miRNAs could be considered important posttranscriptional regulators.
Their expression has been related to the dysregulation of several biological processes
in both innate and adaptive immune responses (5). The impact of infection on miRNA
expression has already been described for several bacteria in different cell models. This
is especially true for macrophages, which play an important role in cytokine secretion,
the immune response, and early recognition and clearance of bacteria (22). For in-
stance, in a model of human macrophages infected with Mycobacterium tuberculosis, it
has been observed that the infection leads to the speciﬁc expression of several miRNAs
that play key roles in immune and inﬂammatory pathways (23). In the context of PD,
up- or downregulation of the expression of several miRNAs, such as miR-155, miR-200,
and miR-146, that are involved in the regulation of several cellular processes, including
the control of TLR sensitivity, the cell cycle, apoptosis, and autophagy, has also been
observed (5). More speciﬁcally, effects on miRNA regulation induced by keystone
pathogens such as P. gingivalis have also been investigated. In macrophages, stimula-
tion by P. gingivalis LPS modulates the expression of miR-24, a negative regulator of
macrophage classical activation (24). In our model, P. gingivalis infection also down-
regulated mmu-miR-211-3p expression; this observation was also visible in a Candida
albicans infection model, contributing to suppression of the host immune response
(19). Interestingly some other miRNAs have already been described as potential regu-
lators of the host immune response induced by P. gingivalis or its virulence factors, such
as miR-146a, which downregulates proinﬂammatory cytokine secretion by blocking TLR
FIG 4 Histological sections. Shown are representative samples of skin and underlying calvarial bone at the middle of the lesion from each of the following
groups: P. gingivalis (Pg) (A to C), combination (P. gingivalis and miR-155 plus anti-miR-2137) (D to F), P. gingivalis and anti-miR-2137 (G to I), and P. gingivalis
and miR-155 (L to N). TRAP staining of bone (bottom row, 200 magniﬁcation) and hematoxylin-and-eosin staining of skin (top row, 100 magniﬁcation;
middle row, 200 magniﬁcation) are shown. Arrows indicate TRAP-stained multinucleated osteoclasts attached to bone and bone resorption lacunae.
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pathways in vitro (25, 26) or in vivo (27). Several other pathways have been identiﬁed
as putative targets of P. gingivalis leading to uncontrolled secretion of cytokines such
as SOCS3 (28).
In our study, the effects of P. gingivalis infection on 1,908 miRNAs were evaluated.
We observed that infection led to speciﬁc modulation of the expression of eight
miRNAs (mmu-miR-155-5p, mmu-miR-211-3p, mmu-miR-2137, mmu-miR-3473b, mmu-
miR-3473e, mmu-miR-6975-5p, mmu-miR-7674-5p, and mmu-miR-8109) when high-
stringency criteria were used.
miR-155 expression is upregulated by P. gingivalis infection. This miRNA is abun-
dantly expressed in immune cells such as macrophages and active B and T cells and in
dendritic cells. It is involved in the immune response, as well as in protection against
the harmful effects of inﬂammation through the modulation of pathways related to
apoptosis, proliferation, and host-pathogen interactions (29). Interestingly, in human
gingival tissues affected by PD, an increase in miR-155 expression has already been
observed (18), with several pathogens seemingly able to increase it. In macrophages
infected with Helicobacter pylori, the increased expression of miR-155 acts as an
inﬂammatory promoter, inducing proinﬂammatory cytokine (TNF-, IL-23, IL-10, IL-8)
secretion (30). However, in our in vitro model of transfection, miR-155 did not modify
the secretion of TNF-, while its inhibition increased TNF- levels signiﬁcantly, dem-
onstrating a potentially differential effect dependent on the type of pathogen, the cell
type, or the method of miRNA delivery.
Surprising results have been obtained regarding the effects of miR-7674 and miR-
8109 on TNF- secretion. Transfection with either mimics or inhibitors of these miRNAs
induced an increase in TNF- secretion. Precise targets associated with TNF- have not
been identiﬁed for these miRNAs yet, and at this point, the precise signiﬁcance of these
results remains unclear. Additional experiments are required to ﬁll this knowledge gap.
Furthermore, some of the miRNA mimics or inhibitors selected increased the
secretion of IL-10 in macrophages, highlighting their potential role in modulation of the
innate immune response. The increase in anti-inﬂammatory IL-10 secretion has already
been observed during P. gingivalis infection and is considered part of the bacterial
survival strategy (31, 32). Therefore, modulation of the secretion of this cytokine
through miRNA expression may be one of the mechanisms involved in the host
response associated with P. gingivalis infection, as suggested by our pathway bioinfor-
matic analysis. However, it is important to take into account that the observed increase
in IL-10 secretion in transfected BMMs was small, emphasizing the need for conﬁrma-
tory experiments regarding their impact on speciﬁc molecular pathways associated
with the secretion of this cytokine.
Since PD is a chronic disease, infection may occur in already activated cells.
Accordingly, the effect of P. gingivalis infection on pretreated macrophages was
evaluated. Our results show that the cell response to infection is modulated by such
pretreatment. For instance, a decrease in TNF- secretion was observed in cells
transfected with miR-155 and infected with P. gingivalis. Therefore, we hypothesized
that modulation of miR-155 expression by P. gingivalis is one of the mechanisms
developed by the bacterium to restrain the host immune response to P. gingivalis
infection. An anti-inﬂammatory effect was also observed when macrophages were
transfected with anti-miR-2137 and infected with P. gingivalis, resulting in ampliﬁcation
of anti-inﬂammatory IL-10 secretion. From a therapeutic point of view, their ability to
reduce the proinﬂammatory aspects and promote anti-inﬂammatory aspects of the
host response may be an interesting strategy to control the adverse effects of P.
gingivalis infection.
Furthermore, our in vitro results were conﬁrmed in vivo in a mouse calvarial model.
This model has often been used to study inﬂammation and bone loss in response to
infection. We elected to use the calvarial model to assess the impact of identiﬁed
miRNA mimics or inhibitors on the modulation of P. gingivalis-induced inﬂammation
and bone resorption (33) for two reasons. The ﬁrst is easy delivery of the miRNA. With
easy access, we were conﬁdent in our abilities to deliver the miRNA to the proper
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location and accurately test for efﬁcacy. Furthermore, it allows us to deliver a precise
dose of miRNAs. The second is speciﬁcity to P. gingivalis pathogenicity. We wanted to
test the effects of the miRNAs identiﬁed on P. gingivalis pathogenicity only and avoid
the oral cavity, as this would have introduced additional confounding factors (i.e.,
microorganisms). Therefore, we elected to use the calvarial model in this study, as the
murine PD model (i.e., oral gavage or infected ligatures) would introduce an additional
unknown factor (host oral ﬂora), which is preferably avoided in proof-of-concept
experiments.
At the histological level, P. gingivalis infection induced bone loss, as reported
previously (34). Interestingly, coinjection with miR-155 or anti-miR-2137 signiﬁcantly
decreased some aspects of the induced lesion, notably its size. Through their modu-
lation of macrophage polarization, as for miR-155 (35), the therapeutic potential of
miRNAs in the treatment of several inﬂammation-related diseases has already been
proposed. Previously, it was shown that miR-155 was able to affect the levels of
expression of other miRNAs (5), which may explain the observed effect in vivo. Such a
role was already suggested for miR-155 in a previous study (36), where this miRNA was
described as having modulated osteoclastogenesis by targeting SOCS1 and MITF.
Interestingly, our in vivomodel showed that the reduction of TNF- by miR-155 was not
enough to signiﬁcantly decrease ICI, bone loss, or osteoclast activity. Further investi-
gation of the role of miR-155 in inﬂammation might reveal an alternative pathway.
Regarding mmu-miR-2137, in vitro results were substantiated in vivo when anti-miR-
2137 was coinjected with P. gingivalis, leading to a reduction in osteoclast activity and
bone loss. This indicated a potential role for anti-miR-2137 in bone metabolism and
revealed that the increase in IL-10 production caused by miR-2137 inhibition was
sufﬁcient to produce a robust reduction in P. gingivalis-induced ICI, bone loss, or
osteoclast activity. However, the injection of the combination group did not affect the
size of the lesion associated with P. gingivalis infection as we had hypothesized. This
may be a consequence of the ability of miR-155 to affect the expression of other
miRNAs (5). This could also be attributed to the fact that we used a lower concentration
of each miRNA because of the inherent toxicity of miRNA seen at a higher concentra-
tion in our in vivo model. More importantly, quantitative histological examination
revealed that the effect of miRNA-155 on TNF- was not sufﬁcient to reduce the strong
inﬂammation produced by P. gingivalis, which in turn could reverse the robust effect of
anti-miR-2137. However, osteoclast activity was signiﬁcantly reduced by this combina-
tion (miRNA-155 and anti-miR-2137).
Cognizant of the calvarial model’s limitations, the present study has demonstrated
proof of principle in the identiﬁcation and conﬁrmation of the roles of speciﬁc miRNAs
in the inﬂammatory process associated with P. gingivalis pathogenicity. The present
results should be conﬁrmed in a speciﬁc model of experimental PD such as an
oral-gavage- or infected-ligature-induced model (33) to evaluate precisely the potential
therapeutic interest of these miRNAs in the context of a more complex lesion induced
by a multispecies complex bioﬁlm such as in PD.
Recently, the roles and functions of miRNAs have been more appreciated in the
context of PD. However, available studies analyzed miRNA expression in healthy and
diseased gingival biopsy specimens without taking the differences in cell populations
into account, leading to biased results (5). To prevent skewed results due to preacti-
vation of macrophage cells, our study focused on BMMs, which can be considered a
naive cell population. Indeed, the macrophage response to infection is certainly under
the inﬂuence of several factors, including preactivation (37), ruling out the use of
peritoneal macrophages.
miRNA research in the periodontal ﬁeld is a work in progress, as knowledge
increases continuously. However, the identiﬁcation of new miRNA sequences calls for
attention. In our study, some of the miRNAs identiﬁed were poorly described in the
literature and the potential molecular pathways involved in their action could only be
approached through bioinformatic analysis. Therefore, further research with other
types of immune and periodontal cells but also speciﬁc in vivomodels of PD (33) should
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pave the way to a better understanding of their role in periodontal disease develop-
ment and to identify their potential use as therapeutics. Their pivotal role in a network
of cellular mechanisms may allow us to use them to target well-identiﬁed pathways
speciﬁcally with the aim to control infection-related processes. The development of
speciﬁc carriers is mandatory to develop highly selective miRNA-based therapies.
MATERIALS AND METHODS
Bacterial strain. P. gingivalis ATCC 33277 (kindly provided by R. Lamont, University of Louisville,
Louisville, KY) was cultured and maintained on enriched tryptic soy agar plates containing a mixture of
deﬁbrinated sheep blood, 5 mg/ml hemin, and 1 mg/ml menadione at 37°C under anaerobic conditions.
Bacterial colonies where then transferred into brain heart infusion medium (Becton, Dickinson and
Company, Sparks, MD) supplemented with the same materials. On the day of infection, bacteria were
centrifuged and washed with phosphate-buffered saline (PBS) and the number of bacteria was deter-
mined by measuring the optical density at 600 nm.
Macrophage cultures. BMMs were harvested as described previously (38). Brieﬂy, bone marrow cells
from femora of donor mice were incubated for 7 days at 37°C in RPMI medium supplemented with L929.
BMMs were cultured in RPMI medium supplemented with 10,000 U/liter penicillin, 100 mg/liter strep-
tomycin, and 10% fetal bovine serum in a humidiﬁed atmosphere with 5% CO2.
Infection of BMMs with P. gingivalis. A total of 1  106 BMMs were plated in six-well plates.
Adherent BMMs were infected with live P. gingivalis at a multiplicity of infection (MOI) of 25 (3). Cells and
supernatants were harvested 3 h after infection with live bacteria.
RNA extraction and microarray analysis. BMMs were washed with cold PBS 3 h after infection, and
the total RNAs were extracted with the miRNeasy minikit (Qiagen, Valencia, CA) according to the
manufacturer’s instructions. Sample integrity was veriﬁed with RNA 6000 Nano Assay RNA chips run in
an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). The RNAs (300 g) were then labeled
with the FlashTag HSR kit (Genisphere Inc., Hatﬁeld, PA) according to the manufacturer’s protocol. The
labeled RNAs were hybridized with miRNA 4.0 arrays (Affymetrix, Santa Clara, CA) for 16 h in GeneChip
Hybridization Oven 640 at 48°C with rotation (60 rpm). The hybridized samples were washed and stained
with Affymetrix Fluidics Station 450. The ﬁrst staining with streptavidin–R-phycoerythrin was followed by
signal ampliﬁcation with a biotinylated goat anti-streptavidin antibody and another streptavidin–R-
phycoerythrin staining (Hybridization, Washing and Staining kit; Affymetrix, Santa Clara, CA). Microarrays
were immediately scanned with Affymetrix GeneArray Scanner 3000 7G Plus (Affymetrix, Santa Clara, CA).
The Affymetrix Expression console software was used for summarization, normalization, and quality
control of the resulting CEL ﬁles. All experiments were performed in triplicate.
Data processing. Raw Affymetrix CEL ﬁles (GeneChip miRNA version 4.0 array) were normalized to
produce probe set level expression values for all mouse and control probe sets with the Affymetrix
Expression Console (version 1.4.1), Robust Multiarray Average (39), and Detection Above BackGround.
The analysis was limited to 1,908 mature mouse miRNAs assessed by the array. A principal-component
analysis was performed with the prcomp R function with expression values that had been normalized
across all of the samples to a mean of 0 and a standard deviation of 1. Analyses of variance was
performed with the f.pvalue function in the sva package (version 3.4.0). Pairwise differential miRNA
expression was assessed with the moderated (empirical Bayesian) t test implemented in the limma
package (version 3.14.4) (i.e., creation of simple linear models with lmFit, followed by empirical Bayesian
adjustments with eBayes). Correction for multiple-hypothesis testing was accomplished with the
Benjamini-Hochberg false-discovery rate (40). All statistical analyses were performed in the R environ-
ment for statistical computing (version 2.15.1).
RT and real-time PCR validation. Three micrograms of total RNA was used for RT-qPCR with the
miScript II RT kit according to the manufacturer’s instructions. Real-time PCR was conducted with the
miScript SYBR green PCR kit and the Bio-Rad RT-PCR system (Bio-Rad, Hercules, CA). All reagents and
primers were purchased from Qiagen, Valencia, CA.
Identiﬁcation and analysis of predicted target genes of differentially expressed miRNAs.
miRWalk 2.0 (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/) (41) was used to identify putative
target genes from eight identiﬁed miRNAs with a predicted P value of 0.05. Interactomic data were
extracted from the STRING 10 database (42), which contains known and predicted physical and
functional PPIs from diverse sources. Only interactions with the highest conﬁdence were selected
(combined score, 0.9). The open-source software platform Cytoscape 3.2.1 (43) was used to visualize
and analyze PPI networks. The clusterMaker2 0.9.5 plugin (44) from Cytoscape, and in particular the MCL
algorithm (45) (granularity parameter of 2.5), was applied to identify topological modules. KEGG pathway
enrichment analysis was performed with DAVID release 6.8 (46) to study the functional signiﬁcance of the
modules.
Transient miRNA transfections. The miScript miRNA mimics used were syn-mmu-miR-155-5p
(miR-155), syn-mmu-miR-2137 (miR-2137), syn-mmu-miR-7674-5p (miR-7674), and syn-mmu-miR-8109
(miR-8109), and the miScript miRNA inhibitors used were anti-mmu-miR-155-5p (anti-miR-155), anti-
mmu-miR-2137 (anti-miR-2137), anti-mmu-miR-7674 (anti-miR-7674), and anti-mmu-miR-8109 (anti-miR-
8109). All were purchased from Qiagen (Valencia, CA). As a control, AllStars Neg. siRNA AF 546 (Qiagen)
was used. One day prior to the transfection, 4  105 cells were seeded into a 24-well plate. Transfection
was performed with HiPerfect Transfection Reagent (Qiagen) according to the manufacturer’s protocol.
BMMs were transfected with miRNA mimics or inhibitors at a ﬁnal concentration of 50 nM and infected
with P. gingivalis (MOI of 25).
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Cytokine analysis. The supernatants of the P. gingivalis-infected BMMs that were transfected with
the miRNA mimics or inhibitors were collected after 24 h of treatment. The levels of TNF- and IL-10 were
evaluated with enzyme-linked immunosorbent assay kits (Life Technologies Corporation, Carlsbad, CA)
according to the manufacturer’s protocol.
Mouse calvarial bone resorption model. The 8- to 12-week-old wild-type C57BL/6J mice used in
this study were purchased from The Jackson Laboratory (Bar Harbor, ME). All experiments involving
animals were approved by the Boston University Institutional Animal Care and Use Committee and were
performed in compliance with relevant animal care and use laws. Regular mouse chow and water were
provided ad libitum. The mice (n  4) were separated into the following four groups: (i) P. gingivalis-
infected mice as a control; (ii) P. gingivalis, 8 g of miR-155, and 8 g of anti-miR-2137 inhibitor (here,
this group is referred to as the combination group); (iii) P. gingivalis and 16 g of miR-155; and (iv) P.
gingivalis and 16 g of anti-miR-2137. The ﬁnal volume of each individual injection was 100 l in PBS.
All of the procedures were done with mice under anesthesia as previously described (47). Anesthesia
was obtained by the intraperitoneal injection of ketamine-xylazine. First, the heads of mice were shaved,
and then P. gingivalis (5  108 CFU in 100 l of PBS) and the mmu-miR 155 mimic, the mmu-miR 2137
inhibitor, or both were injected subcutaneously at the same site. Injections were carried out with a
30.5-gauge needle at a point on the midline of the skull between the ears and eyes. Mice were sacriﬁced
7 days after the injection. The size of the lesion resulting from the injection in each animal (area in square
millimeters) was analyzed with ImageJ.
Histological analysis. The calvarium of each mouse was ﬁxed in 2% paraformaldehyde in PBS
(Affymetrix, Inc., Cleveland, OH) for 2 h at room temperature and refrigerated in PBS until ready for
further processing. Samples were embedded in an optimal cutting temperature compound (Fisher
HealthCare, Houston, TX) and frozen at the time of sectioning. Sections of 5 to 8 m were stained with
hematoxylin and eosin and prepared for further analysis. To analyze osteoclast activity, a tartrate-
resistant acid phosphatase (TRAP) assay was performed according to an already established protocol (48).
To quantify the histological sections, samples were evaluated by double-blinded examiners according to
three different scoring protocols. (i) Calvarial bone resorption was scored on a scale of 0 through 4, with
0 corresponding to no calvarial bone resorption, 1 meaning that one-fourth of the calvarial bone was
affected but there was no through-and-through penetration, 2 meaning that half of the calvarial bone
was affected but there was no through-and-through penetration, 3 meaning that half of the calvarial
bone was affected with through-and-through bone penetration 1 mm in width, and 4 meaning that
more than half of the calvarial bone was affected with through-and-through bone penetration 1 mm
wide. (ii) Osteoclast activity was scored on a scale of 0 to 3, with 0 corresponding to no osteoclast activity
with no sign of bone resorption; 1 corresponding to the presence of some osteoclast lacunae with
minimum bone resorption; 2 corresponding to the presence of 5 to 10 osteoclast lacunae with bone
resorption, and 3 corresponding to the presence of 10 osteoclast lacunae and severe bone resorption.
(iii) ICI was scored on a scale of 0 through 5, with 0 corresponding to no sign of inﬂammation, 1
corresponding to incipient ICI in the derma/subderma, 2 corresponding to mild ICI in the derma/
subderma, 3 corresponding to moderate ICI in the derma/subderma and scarce inﬂammation in the
surrounding bone, 4 corresponding to advanced ICI in the derma/subderma and mild inﬂammation in
the surrounding bone, and 5 corresponding to severe ICI in the derma/subderma and advanced
inﬂammation in the surrounding bone.
Statistical analysis. Data were analyzed for statistical signiﬁcance with XLStat (Addinsoft, New York,
NY). P values were calculated with the Mann-Whitney t test.
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